ストックスクリーナーアプリを入手
10.12
0.69%
-0.07
アフターアワーズ：
10.12
前日終値:
$10.19
開ける：
$10.1
24時間の取引高:
120.06K
Relative Volume:
0.34
時価総額：
$88.07M
収益：
-
当期純損益:
$-6.42M
株価収益率:
-1.8067
EPS:
-5.6013
ネットキャッシュフロー:
$-7.45M
1週間 パフォーマンス:
+2.74%
1か月 パフォーマンス:
+40.17%
6か月 パフォーマンス:
+334.33%
1年 パフォーマンス:
-40.61%
1日の値動き範囲:
$10.01
$10.39
1週間の範囲:
$9.212
$10.39
52週間の値動き範囲:
$1.80
$20.63
Cervomed Inc Stock (CRVO) Company Profile
CRVO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRVO
Cervomed Inc
|
10.12 | 88.68M | 0 | -6.42M | -7.45M | -5.6013 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-13 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2024-12-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-12-11 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2024-12-11 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2024-12-10 | ダウングレード | D. Boral Capital | Buy → Hold |
| 2024-12-06 | 開始されました | ROTH MKM | Buy |
| 2024-12-05 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-18 | 開始されました | Chardan Capital Markets | Buy |
| 2024-07-26 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-15 | 開始されました | Canaccord Genuity | Buy |
| 2020-11-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2018-03-21 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Cervomed Inc (CRVO) 最新ニュース
CervoMed Inc. stock chart pattern explainedWeekly Earnings Recap & Real-Time Stock Price Movement Reports - Newser
Applying sector rotation models to CervoMed Inc.Insider Selling & Free Verified High Yield Trade Plans - Newser
Can machine learning forecast CervoMed Inc. recoveryWeekly Market Report & Weekly Top Gainers Alerts - Newser
What MACD signals say about CervoMed Inc.2025 Price Action Summary & Step-by-Step Swing Trade Plans - Newser
Best data tools to analyze CervoMed Inc. stockInflation Watch & Consistent Return Investment Signals - Newser
Leading vs lagging indicators on CervoMed Inc. performanceMarket Performance Report & Daily Market Momentum Tracking - Newser
CervoMed’s Promising Developments and Financial Stability Drive Buy Rating with $20 Price Target - TipRanks
FY2025 EPS Estimates for CervoMed Boosted by Chardan Capital - Defense World
Roth Capital Estimates CervoMed’s Q3 Earnings (NASDAQ:CRVO) - Defense World
Is CervoMed Inc. a turnaround storyMarket Trend Summary & Real-Time Volume Analysis - newsimpact.co.kr
CervoMed (NASDAQ:CRVO) Stock Price Expected to Rise, D. Boral Capital Analyst Says - Defense World
Chardan Capital Reiterates Buy Rating for CervoMed (NASDAQ:CRVO) - Defense World
CervoMed Inc. stock trend forecastSecure Buy Strategy Based on Risk Parameters - Newser
Can CervoMed Inc. hit a new high this monthYield Curve Outlook and Long-Term Implication Summary - Newser
CervoMed Reports Promising Trial Results and Financial Update - MSN
CCORF Maintains CervoMed(CRVO.US) With Buy Rating, Maintains Target Price $27 - 富途牛牛
CervoMed Reports Second Quarter 2025 Financial Results and Provi - GuruFocus
CervoMed Reports Second Quarter 2025 Financial Results and Provides Corporate Updates - TradingView
Breakthrough: CervoMed's Dementia Drug Cuts Disease Progression Risk by 54% in Phase 2b Trial - Stock Titan
CervoMed stock price target raised to $15 from $10 at D. Boral Capital By Investing.com - Investing.com South Africa
CervoMed stock price target raised to $15 from $10 at D. Boral Capital - Investing.com Canada
How CervoMed Inc. stock performs during market volatilityTrend Confirmation Scanner with Entry Focus - Newser
CervoMed Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
CervoMed 2025 Q2 Earnings Deepening Losses Amid Revenue Decline - AInvest
12,028 Shares in CervoMed Inc. (NASDAQ:CRVO) Purchased by Bank of New York Mellon Corp - Defense World
Cervomed Inc. shares fall 1.69% intraday after corporate presentation on Neflamapimod in dementia with Lewy bodies. - AInvest
How to track smart money flows in CervoMed Inc.Free Buy Low Sell High Stock Watch - Newser
CervoMed Shares Business and Financial Updates Online - TipRanks
CervoMed to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
CervoMed Reveals Neurologic Treatment Progress: Key Presentation at Major Growth Conference Next Week - Stock Titan
Is CervoMed Inc. stock overvalued or undervaluedDouble or triple returns - Jammu Links News
What is the risk reward ratio of investing in CervoMed Inc. stockUnmatched profit potential - Jammu Links News
What analysts say about CervoMed Inc. stockAchieve breakthrough financial results - Jammu Links News
When is CervoMed Inc. stock expected to show significant growthBreakthrough investment results - Jammu Links News
What are CervoMed Inc. company’s key revenue driversMaximize portfolio value with smart investment plans - Jammu Links News
What is CervoMed Inc. company’s growth strategyFree Stock Market Forecast Reports - Jammu Links News
Should I hold or sell CervoMed Inc. stock in 2025Amplify your gains with low-risk picks - Jammu Links News
What drives CervoMed Inc. stock priceExponential wealth increase - Jammu Links News
Is CervoMed Inc. a growth stock or a value stockHigh-yield trading alerts - Jammu Links News
Is it the right time to buy CervoMed Inc. stockBreakout stock performance - jammulinksnews.com
CervoMed Inc. (NASDAQ:CRVO) Surges 53%; Retail Investors Who Own 48% Shares Profited Along With Insiders - 富途牛牛
CervoMed Shares Surge After Promising Dementia Drug Trial Results - MSN
How volatile is CervoMed Inc. stock compared to the marketSwing Trade Updates For Consistent Profits - Jammu Links News
CervoMed Dementia Drug Slows Disease Progression In Study: Retail Loads Up On The Stock - Stocktwits
Combining machine learning predictions for CervoMed Inc.Trade Analysis Summary & Low Risk Entry Point Tips - Newser
CervoMed Inc. Forms Double Bottom Pattern — Eyes on BreakoutAlpha Driven Watchlist With Alerts Published - metal.it
CERVOMED INC (CRVO) Surges 11.6%: Is This an Indication of Further Gains? - MSN
Sentiment Turns Positive on CervoMed Inc. — Reversal AheadReliable Alerts for Daily Stock Movers Released - metal.it
Canaccord Genuity raises CervoMed stock price target to $27 on improved approval odds - Investing.com Nigeria
CervoMed (CRVO) Target Price Increased Following Positive Drug T - GuruFocus
Published on: 2025-07-29 09:25:15 - metal.it
Cervomed Inc (CRVO) 財務データ
収益
当期純利益
現金流量
EPS
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):